http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Cryptocurrency Billionaire Sells His South Florida Penthouse for $28.6 Million
-
The Hackett Group® Recognized in U.S. News & World Report’s 2025-2026 Best Companies to Work For
-
Crush Colossal Kaiju with a Game-Changing Blow: KAIJU NO. 8 THE GAME Unveils Details for Original Story!
-
UroGen Announces Data at ASCO 2025 Annual Meeting on UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
-
Liberty Star Announces Successful SAM Registration, Enhancing Opportunities for Federal Grants
-
Wildfire Smoke is Already Suffocating Canada – Here’s How to Save Your Lungs
-
Just in Time for Summer: Tony Lama Introduces the Playa Collection
-
DR. ALAN CHEN AND DR. F. WINSTON GWATHMEY RECOGNIZED BY ALLOSOURCE WITH THE DR. STEVEN GITELIS INSPIRATION AWARD FOR HONORING THE GIFT OF DONATION
-
ImmunityBio (IBRX) receives FDA Expanded Access for Cancer BioShield platform
-
Phenomenex Launches Cutting-Edge 0.15 mm ID Micro LC Columns and Traps for Precision Low-Flow Applications
-
Lenox Advisors Celebrates 9 Years as a Great Place to Work
-
Bondex’s Native Utility Token $BDXN Secures Listing on Binance Alpha and Futures
-
Color Health Presents Findings on National Telehealth-Based Cancer Screening Programs at ASCO 2025
-
Bondex’s Native Utility Token $BDXN Secures Listing on Binance Alpha and Futures
-
ASUS Wins 41 Prestigious Red Dot Design Awards for Product Design 2025, Showcasing World-Class Excellence
-
Suffolk Hires Cotton McNutt to Help Lead Mission Critical Operation to Meet Growing Demand for Data Center Construction Nationally
-
NYLI MacKay DefinedTerm Muni Opportunities Fund Declares Monthly Dividend Distribution for June 2025
-
ImmunityBio Receives FDA Expanded Access Authorization for Landmark Treatment of Lymphopenia With ANKTIVA®, the Cancer BioShield™ Platform, in Patients With Solid Tumors
-
Tech:NYC + NYCEDC launch Obviously NYC celebrating NYC's tech industry's growth and rise as a key driver of the city's economy and future
-
Instawork Announces Appointment of Katherine August-deWilde as Independent Board Member
-
Check Point Software Technologies Recognized as a Best Company to Work For by U.S. News & World Report
-
Karl Dahlgren and Judy Mulcahy Join National Restaurant Association Executive Leadership
-
Guidewire Wins Six XCelent Awards and ‘Luminary’ Distinction in Celent’s Regional Reviews of P&C Policy Administration Systems
-
Worksport Ltd (WKSP) Surpasses Monthly Sales Record in April on Strong AL4 Performance
-
Worksport Surpasses Monthly Sales Record in April on Strong AL4 Performance
-
Safe & Green (SGBX) to Acquire Giant Containers
-
iRocket and Wilbur Ross-Backed BPGC Acquisition Corp. Announce a $400 Million Merger Letter of Intent for a Business Combination to Transform the Space Launch Industry and List iRocket on Nasdaq
-
Amprius Sets June 2025 Events Schedule
-
Safe & Green Holdings Corp. Signs Letter of Intent to Acquire Giant Containers Inc.
-
BTCS Inc. Utilizes Crypto.com and Acquires 1,000 ETH, Expanding Ethereum Holdings to 13,500 ETH
-
Safe & Green Holdings Corp. Signs Letter of Intent to Acquire Giant Containers Inc.
-
PKF O'Connor Davies Welcomes Rainer & Company
-
Cunard launches 195 new voyages, visiting 115 destinations across the globe
-
Scholar Rock Holding Corp. (SRRK) Appoints as Rebecca McLeod Chief Brand Officer and U.S. General Manager
-
National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening
-
Viatris Inc (VTRS) Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142
-
Toshiba Awarded National Cooperative Contract
-
Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
-
Scholar Rock Appoints Rebecca McLeod Chief Brand Officer and U.S. General Manager
-
Lightbridge Completes Final Experiment Design for Designated ATR Core Position
-
Operation HOPE and Financial Literacy for All Celebrate Record-Breaking Success of Green Socks Day Challenge
-
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
-
Dr Manfred Knof joins DeFi Technologies as Chairman of Valour and Strategic Advisor
-
ReElement Technologies Secures Anchor Investment from South African Firm Novare Holdings to Catalyze Rare Earth Element Refining Expansion in America's Heartland
-
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
-
BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
-
Canadian Gold Corp. Acquires Assigned Option from Searchlight Resources Inc. of Flin Flon North Property, Significantly Expanding Control of the Tartan Shear Zone
-
Auxly Announces Annual General Meeting of Shareholders
-
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
-
Dow (DOW) to Sell its 50% Ownership in DowAksa Joint Venture
